Trial intelligence / Profile preview

Duloxetine for postoperative pain after abdominal hysterectomy

IRCT20120922010900N5Phase 3Completed

Sponsor
Kerman University of Medical Sciences
Start
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of duloxetine in postoperative pain (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Pain intensity in recovery, Analgesic consumption in first 24 hours and 3 more. Started Feb 2018; status: completed.

02

Drugs

duloxetine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20120922010900N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120922010900N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call